DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



CD30+, large T-cell lymphoma: diagnostic distinction and management.

Author(s): Parlette EC, Tabor CA

Affiliation(s): Uniformed Services University of Health Sciences, Department of Dermatology, US Naval Hospital, Okinawa, Japan. ecparlette@yahoo.com

Publication date & source: 2006-10-31, Dermatol Online J., 12(6):8.

Publication type: Case Reports

Cutaneous T-cell lymphoma (CTCL) has a variable presentation and comprises a broad diagnostic group. Histologic and immunophenotypic confirmation is needed to establish a precise diagnosis. Once the categorization is determined, prognosis and therapeutic algorithms unfold. Primary cutaneous, CD-30+, anaplastic, large T-cell lymphoma represents an indolent form of CTCL that often spontaneously involutes.

Page last updated: 2007-02-12

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009